Brightcove Launches ‘Ad Monetization’ Service for Media Clients, Establishes Global Advertising Operations Team
7.3.2023 17:15:00 EET | Business Wire | Press release
Brightcove (NASDAQ: BCOV), the world’s most trusted streaming technology company, today announced the launch of Brightcove Ad Monetization, a new bespoke service designed for media companies to better monetize their content. To supplement the service, the company also created a new global advertising operations team to support media organizations and help them maximize their advertising strategy and revenue.
“Advertising-supported streaming is a fast-growing, multi-billion-dollar business we have supported for many years,” said Marc DeBevoise, CEO of Brightcove. “As a valued partner to our media customers, Brightcove Ad Monetization extends our commitment to providing them with the best products and services to power their video content, optimize their advertising strategy, and now – for the first time – truly drive and maximize their advertising revenue.”
Brightcove Ad Monetization builds on Brightcove’s recently announced strategic partnership with Magnite, the world's largest independent sell-side advertising platform. Through the integration of Magnite and SpringServe, Brightcove now offers an advertising monetization service with end-to-end solutions for media companies to generate additional revenue from their advertising strategy.
Brightcove Ad Monetization will help media companies realize maximum, measurable returns on advertising with actionable insights. The solution supports the monetization of live and video-on-demand (VOD) content with improved yield optimization to fill unsold ad inventory and increase revenue. It includes client-side advertising insertion (CSAI) and server-side advertising insertion (SSAI) capabilities for web players, iOS, Android and connected TV platforms. Brightcove Ad Monetization also seamlessly integrates into independent and existing advertising servers, including Google Ad Manager and FreeWheel.
Companies that utilize the service will benefit from the expertise of Brightcove and receive direct support from its newly established global advertising operations team. Under the leadership of David Beck, Chief Strategy and Corporate Development Officer, the new team will consult directly with clients to optimize their advertising strategy, budget and content. From onboarding to implementation and refining the strategy, the team will tap into its deep insights and expertise to help customers every step of the way, no matter where they are on their advertising journey.
Beck has appointed Michael Dorf as the first Vice President of Global Ad Operations to build the team and help media companies monetize their content. “Advertising is constantly evolving and increasingly complicated for many media companies. Brightcove is determined to reduce the friction in the process, making it easier and more profitable for our clients,” shared Beck. “To do this, we built a new expert team. I’m excited to welcome Michael Dorf to lead our global advertising operations. His wealth of knowledge and experience in the media and advertising world will help customers better deliver the right ads to the right people to improve delivery and revenue.”
Dorf is an experienced revenue operations leader with 15 years of experience in the industry. He most recently worked at TelevisaUnivision as the Vice President of Revenue Operations, where he successfully rebuilt a cross-functional operations team to support direct and programmatic sales channels. Prior to that, he held various senior leadership roles with FreeWheel, a Comcast company, Condé Nast, and Maker Studios, a subsidiary of The Walt Disney Company.
For more information, visit Brightcove.com.
About Brightcove Inc.
Brightcove creates the world’s most reliable, scalable, and secure streaming technology solutions to build a greater connection between companies and their audiences, no matter where they are or on which devices they consume content. In more than 60 countries, Brightcove’s intelligent video platform enables businesses to sell to customers more effectively, media leaders to stream and monetize content more reliably, and every organization to communicate with team members more powerfully. With two Technology and Engineering Emmy® Awards for innovation, uptime that consistently leads the industry, and unmatched scalability, we continuously push the boundaries of what video can do. Follow LinkedIn, Twitter, Facebook and Instagram. Visit www.brightcove.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230307005399/en/
Contact information
Media
Joseph J. Nuñez, Director of Global Communications and Public Relations
jnunez@brightcove.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release
With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release
Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
